Methotrexat Accord

Methotrexate, the active ingredient in Methotrexat Accord, is an antimetabolite presented as a sterile injectable for intraarterial, intramuscular, intrathecal use. It treats several autoimmune and oncologic conditions in adults and children as prescribed by a physician.

GNH USA supplies Methotrexat Accord as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Methotrexate is an antimetabolite used in autoimmune and oncologic disease pathways.

- Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: decreases skin cell proliferation and improves plaque severity. - Acute lymphoblastic leukemia: interferes with malignant lymphoblast replication. - Osteosarcoma: limits tumor growth by inhibiting DNA synthesis. - Gestational trophoblastic disease: promotes resolution of abnormal trophoblastic tissue.

Methotrexate may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea and vomiting. - Fatigue or weakness. - Mucositis or mouth sores. - Alopecia (hair loss). - Elevated liver enzymes. - Mild skin rash.

Serious or Rare Side Effects: - Bone marrow suppression leading to pancytopenia. - Severe hepatotoxicity or fibrosis. - Pulmonary toxicity, including interstitial pneumonitis. - Life‑threatening infections due to immunosuppression. - Acute renal failure. - Anaphylactic or severe hypersensitivity reactions.

When using Methotrexat Accord, several safety measures should be observed.

- Monitor liver function: perform baseline and periodic liver enzyme tests. - Monitor blood counts: check complete blood count regularly to detect myelosuppression. - Avoid use in pregnancy: contraindicated (Category X) and requires effective contraception. - Adjust dose in renal impairment: assess renal function before initiation and during therapy. - Limit alcohol consumption: reduces additional hepatic stress. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Methotrexate interacts with several medicines that can alter its safety or efficacy.

Major Interactions (Avoid): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase methotrexate toxicity. - Trimethoprim‑sulfamethoxazole: potentiates myelosuppression. - Live vaccines: risk of severe infection. - Phenytoin and other enzyme‑inducing anticonvulsants: reduce methotrexate levels. - High‑dose folic acid supplements: may diminish therapeutic effect.

Moderate Interactions (Monitor Closely): - Proton‑pump inhibitors: may affect renal clearance. - ACE inhibitors or angiotensin‑II blockers: increase risk of renal dysfunction. - Alcohol: adds hepatic burden. - Antacids containing aluminum or magnesium: can affect absorption. - Sulfonylureas: may enhance hypoglycaemia risk.